diaziquone has been researched along with Benign Cerebellar Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjornsson, TD; Falletta, JM; Friedman, HS; Schold, SC | 1 |
| Kees, UR; Sterling-Levis, K; Tobias, V; White, L | 1 |
| Albright, RE; Bullard, DE; Burger, PC; Cairncross, JG; DeLong, ER; Friedman, HS; Khandekar, JD; Mahaley, MS; Schold, SC; Vick, NA | 1 |
3 other study(ies) available for diaziquone and Benign Cerebellar Neoplasms
| Article | Year |
|---|---|
Treatment of patients with recurrent primary brain tumors with AZQ.
Topics: Adolescent; Adult; Aged; Aziridines; Azirines; Benzoquinones; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Ependymoma; Female; Glioma; Humans; Male; Medulloblastoma; Middle Aged | 1984 |
Medulloblastoma/primitive neuroectodermal tumour studied as a Matrigel enhanced subcutaneous xenograft model.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Aziridines; Benzoquinones; Biocompatible Materials; Carboplatin; Cerebellar Neoplasms; Cisplatin; Collagen; Cyclophosphamide; Drug Combinations; Immunophenotyping; Laminin; Medulloblastoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neuroectodermal Tumors, Primitive; Proteoglycans; Treatment Outcome; Vincristine; Xenograft Model Antitumor Assays | 2001 |
Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasms.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Aziridines; Benzoquinones; Carmustine; Cerebellar Neoplasms; Child; Dacarbazine; Drug Evaluation; Glioblastoma; Humans; Middle Aged; Neoplasm Recurrence, Local; Statistics as Topic | 1987 |